Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Merck discontinues Phase 3 trial for lung cancer combo drug
When compared to patients in the control arm, patients in the vibostolimab and pembrolizumab fixed-dose combination arm…
Obesity drug tirzepatide approval in China strengthens market position amid GLP-1 agonist…
Benemae’s benaglutide injection (Feisumei) was the first innovator approved for obesity in July 2023 in China followed by Novo…
What effect does X-ray inspection have on pharma products?
Pharma manufacturers continue to have concerns over the effect that X-ray inspection could have on their medicines. Are they right…
Nutraceutical brand Aurelle Health launches in India
Focusing on women’s hormonal health, Aurelle has launched products for hair health, skin health, gut health and weight management…
DCGI waives off local trials for drugs approved in well-regulated markets
The countries on the list include the US, UK, Japan, Australia, Canada and the EU
Novartis’ kidney disease drug Fabhalta receives US FDA approval
Fabhalta specifically targets the alternative complement pathway of the immune system. When overly activated in the kidneys, the…
FDA approves first Nalmefene Hydrochloride auto-injector to reverse opioid overdose
The newly approved product delivers 1.5 milligrams (mg) of nalmefene under the skin (subcutaneous) or into muscle (intramuscular)…
Computational protocol provides cheaper route to manage cholesterol levels
Researchers propose a new computational protocol to predict and identify the alternative binding pockets and hotspots on a protein…
Alembic gains USFDA final approval for Acitretin Capsules USP, 10 mg, 17.5 mg, and 25 mg
Acitretin Capsules USP, 10 mg, 17.5 mg, and 25 mg have an estimated market size of $ 21 million for twelve months ending June 2024…